Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
George, S
Title
Protocol to drive human monocyte-to-macrophage polarization in vitro using tumor conditioned media.
Citation
STAR protocols; 2022 Sep 19; 3(4) pg101666
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
First Author
Bent, E H
Title
Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy.
Citation
Nature communications; 2021 Oct 28; 12(1) pg6218
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
First Author
Aguilar-Bretones, M
Title
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.
Citation
The Journal of clinical investigation; 2021 Nov 1; 131(21)
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
First Author
Yao, Y
Title
Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.
Citation
Nature immunology; 2021 Sep; 22(9) pg1127-1139
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
First Author
Le, K
Title
Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis.
Citation
Blood advances; 2021 Jul 27; 5(14) pg2863-2878
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
First Author
Nienałtowski, K
Title
Fractional response analysis reveals logarithmic cytokine responses in cellular populations
Citation
Nature communications; 2021 Jul 7; 12(1) pg4175
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
First Author
Reyes, M
Title
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.
Citation
Science translational medicine; 2021 Jun 16; 13(598)
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
First Author
Zhang, Y
Title
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
Citation
Proceedings of the National Academy of Sciences of the United States of America; 2021 Jun 8; 118(23)
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
First Author
Cunningham, S
Title
Rapid generation of monocyte-derived antigen-presenting cells with dendritic cell-like properties.
Citation
Transfusion; 2021 Jun; 61(6) pg1845-1855
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
First Author
Hu, G
Title
High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming.
Citation
Nature communications; 2021 Feb 3; 12(1) pg773
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Human
in vitro
Mouse
in vitro
Mouse
in vitro
showing 10 of 200